Neurology 2000;54:2061-2066
© 2000 American Academy of Neurology
Articles
Effects of estrogen on cognition, mood, and cerebral blood flow in AD
A controlled study
P. N. Wang, MD,
S. Q. Liao, MD,
R. S. Liu, MD,
C. Y. Liu, MD,
H. T. Chao, MD,
S. R. Lu, MD,
H. Y. Yu, MD,
S. J. Wang, MD and
H. C. Liu, MD
From The Neurological Institute (Drs. P.N. Wang, Lu, Yu, Wang, and H.C. Liu), Department of Nuclear Medicine (Drs. Liao and R.S. Liu), Department of Obstetrics and Gynecology (Dr. Chao), Taipei Veterans General Hospital & National Yang-Ming University School of Medicine, Taipei; and the Department of Psychiatry (Dr. C.Y. Liu), Chang-Gung Medical College, Taoyuan, Taiwan.
Address correspondence and reprint requests to Dr. Hsiu-Chih Liu, The Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan; e-mail: hcliu{at}vghtpe.gov.tw
OBJECTIVE: To examine the effects of estrogen therapy on cognition, mood, and cerebral blood flow in patients with AD.
BACKGROUND: Some studies have suggested estrogen may be effective in the treatment of AD. However, most of these studies were not controlled adequately.
METHODS: Fifty female AD patients were recruited in a randomized, double-blind, placebo-controlled 12-week trial. Each member of the estrogen-treated group received conjugated estrogen (Premarin) 1.25 mg/day. The primary outcome measures were the Cognitive Ability Screening Instrument (CASI), Clinical Dementia Rating (CDR), and Clinician Interview-Based Impression of Change (CIBIC-plus). The secondary outcome measures were Behavioral Pathology in Alzheimer’s Disease (BEHAVE-AD), Hamilton Anxiety Rating Scale (HARS), Hamilton Depression Rating Scale (HDRS), and 99mTc hexamethylpropylene amine oxime SPECT of the brain.
RESULTS: No meaningful differences were found between the outcome measures (CASI, CDR, CIBIC-plus, BEHAVE-AD, HARS, HDRS, and cerebral blood flow) taken from the estrogen-treated group and those from the control group.
CONCLUSION: A 1.25-mg/day dose of Premarin administered for 12 consecutive weeks does not produce a meaningful effect on cognitive performance, dementia severity, behavior, mood, and cerebral perfusion in female AD patients. Because estrogen therapy has been suspected of yielding adverse effects, and its therapeutic effectiveness is in doubt, additional evaluation of its role in AD treatment ought to be conducted.
Key words: Estrogen—Dementia—AD—Cognition—Depression—Cerebral blood perfusion.
This article has been cited by other articles:
|
|
|
|
 
M. L. S. Gass, S. S. Bassuk, and J. E. Manson
Reassessing Benefits and Risks of Hormone Therapy
American Journal of Lifestyle Medicine,
January 1, 2009;
3(1):
29 - 43.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. B. Petitti, V. C. Crooks, V. Chiu, J. G. Buckwalter, and H. C. Chui
Incidence of Dementia in Long-term Hormone Users
Am. J. Epidemiol.,
March 15, 2008;
167(6):
692 - 700.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. W. Hogue Jr, K. Freedland, T. Hershey, R. Fucetola, A. Nassief, B. Barzilai, B. Thomas, S. Birge, D. Dixon, K. B. Schechtman, et al.
Neurocognitive Outcomes Are Not Improved by 17{beta}-Estradiol in Postmenopausal Women Undergoing Cardiac Surgery
Stroke,
July 1, 2007;
38(7):
2048 - 2054.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. K. Marriott, K. R. McGann-Gramling, B. Hauss-Wegrzyniak, L. C. Sheldahl, R. A. Shapiro, D. M. Dorsa, and G. L. Wenk
Brain Infusion of Lipopolysaccharide Increases Uterine Growth as a Function of Estrogen Replacement Regimen: Suppression of Uterine Estrogen Receptor-{alpha} by Constant, But Not Pulsed, Estrogen Replacement
Endocrinology,
January 1, 2007;
148(1):
232 - 240.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Burns and J. O'Brien
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
J Psychopharmacol,
November 1, 2006;
20(6):
732 - 755.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. L. Turgeon, M. C. Carr, P. M. Maki, M. E. Mendelsohn, and P. M. Wise
Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies
Endocr. Rev.,
October 1, 2006;
27(6):
575 - 605.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. N. Krause, S. P. Duckles, and D. A. Pelligrino
Influence of sex steroid hormones on cerebrovascular function
J Appl Physiol,
October 1, 2006;
101(4):
1252 - 1261.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. H. Lu, D. A. Masterman, R. Mulnard, C. Cotman, B. Miller, K. Yaffe, E. Reback, V. Porter, R. Swerdloff, and J. L. Cummings
Effects of Testosterone on Cognition and Mood in Male Patients With Mild Alzheimer Disease and Healthy Elderly Men
Arch Neurol,
February 1, 2006;
63(2):
177 - 185.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. A. Rippon, M. X. Tang, J. H. Lee, R. Lantigua, M. Medrano, and R. Mayeux
Familial Alzheimer disease in Latinos: Interaction between APOE, stroke, and estrogen replacement
Neurology,
January 10, 2006;
66(1):
35 - 40.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Green, K. Bales, S. Paul, and G. Bu
Estrogen Therapy Fails to Alter Amyloid Deposition in the PDAPP Model of Alzheimer's Disease
Endocrinology,
June 1, 2005;
146(6):
2774 - 2781.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. W. Baum
Sex, Hormones, and Alzheimer's Disease
J Gerontol A Biol Sci Med Sci,
June 1, 2005;
60(6):
736 - 743.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S R Davis, I Dinatale, L Rivera-Woll, and S Davison
Postmenopausal hormone therapy: from monkey glands to transdermal patches
J. Endocrinol.,
May 1, 2005;
185(2):
207 - 222.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Shumaker, C. Legault, L. Kuller, S. R. Rapp, L. Thal, D. S. Lane, H. Fillit, M. L. Stefanick, S. L. Hendrix, C. E. Lewis, et al.
Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women: Women's Health Initiative Memory Study
JAMA,
June 23, 2004;
291(24):
2947 - 2958.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. S. Schneider
Estrogen and Dementia: Insights From the Women's Health Initiative Memory Study
JAMA,
June 23, 2004;
291(24):
3005 - 3007.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Okun, M. R. DeLong, J. Hanfelt, M. Gearing, and A. Levey
Plasma testosterone levels in Alzheimer and Parkinson diseases
Neurology,
February 10, 2004;
62(3):
411 - 413.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J-C Lambert, N Coyle, and C Lendon
The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease
J. Med. Genet.,
February 1, 2004;
41(2):
104 - 112.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. W. Rau, D. B. Dubal, M. Bottner, L. M. Gerhold, and P. M. Wise
Estradiol Attenuates Programmed Cell Death after Stroke-Like Injury
J. Neurosci.,
December 10, 2003;
23(36):
11420 - 11426.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. W. Rau, D. B. Dubal, M. Bottner, and P. M. Wise
Estradiol Differentially Regulates c-Fos after Focal Cerebral Ischemia
J. Neurosci.,
November 19, 2003;
23(33):
10487 - 10494.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W J Cutter, R Norbury, and D G M Murphy
Oestrogen, brain function, and neuropsychiatric disorders
J. Neurol. Neurosurg. Psychiatry,
July 1, 2003;
74(7):
837 - 840.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Shumaker, C. Legault, S. R. Rapp, L. Thal, R. B. Wallace, J. K. Ockene, S. L. Hendrix, B. N. Jones III, A. R. Assaf, R. D. Jackson, et al.
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial
JAMA,
May 28, 2003;
289(20):
2651 - 2662.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. N. McLay, P. M. Maki, and C. G. Lyketsos
Nulliparity and Late Menopause Are Associated With Decreased Cognitive Decline
J Neuropsychiatry Clin Neurosci,
May 1, 2003;
15(2):
161 - 167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. B. Sherwin
Estrogen and Cognitive Functioning in Women
Endocr. Rev.,
April 1, 2003;
24(2):
133 - 151.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Whitmer, M. N. Haan, J. W. Miller, and K. Yaffe
Hormone Replacement Therapy and Cognitive Performance: The Role of Homocysteine
J Gerontol A Biol Sci Med Sci,
April 1, 2003;
58(4):
M324 - M330.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Clark and J. H.T. Karlawish
Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies
Ann Intern Med,
March 4, 2003;
138(5):
400 - 410.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Thal, R. G. Thomas, R. Mulnard, M. Sano, M. Grundman, and L. Schneider
Estrogen Levels Do Not Correlate With Improvement in Cognition
Arch Neurol,
February 1, 2003;
60(2):
209 - 212.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. den Heijer, M. I. Geerlings, A. Hofman, F. H. de Jong, L. J. Launer, H. A. P. Pols, and M. M. B. Breteler
Higher Estrogen Levels Are Not Associated With Larger Hippocampi and Better Memory Performance
Arch Neurol,
February 1, 2003;
60(2):
213 - 220.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.S. Rigaud, G. Andre, B. Vellas, J. Touchon, and J.J. Pere
No additional benefit of HRT on response to rivastigmine in menopausal women with AD
Neurology,
January 14, 2003;
60(1):
148 - 149.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Markowska and A. V. Savonenko
Effectiveness of Estrogen Replacement in Restoration of Cognitive Function after Long-Term Estrogen Withdrawal in Aging Rats
J. Neurosci.,
December 15, 2002;
22(24):
10985 - 10995.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Resnick and V. W. Henderson
Hormone Therapy and Risk of Alzheimer Disease: A Critical Time
JAMA,
November 6, 2002;
288(17):
2170 - 2172.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. M. Fillit
The Role of Hormone Replacement Therapy in the Prevention of Alzheimer Disease
Arch Intern Med,
September 23, 2002;
162(17):
1934 - 1942.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. R. Ott, D. Belazi, and K. L. Lapane
Cognitive Decline Among Female Estrogen Users in Nursing Homes
J Gerontol A Biol Sci Med Sci,
September 1, 2002;
57(9):
M594 - M598.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. B. Petitti, J. G. Buckwalter, V. C. Crooks, and V. Chiu
Prevalence of Dementia in Users of Hormone Replacement Therapy as Defined by Prescription Data
J Gerontol A Biol Sci Med Sci,
August 1, 2002;
57(8):
M532 - M538.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. M. Fillit, R. N. Butler, A. W. O'Connell, M. S. Albert, J. E. Birren, C. W. Cotman, W. T. Greenough, P. E. Gold, A. F. Kramer, L. H. Kuller, et al.
Achieving and Maintaining Cognitive Vitality With Aging
Mayo Clin. Proc.,
July 1, 2002;
77(7):
681 - 696.
[Abstract]
[PDF]
|
|
|
|
|
|
|
V. Senanarong, S. Vannasaeng, N. Poungvarin, S. Ploybutr, S. Udompunthurak, P. Jamjumras, L. Fairbanks, and J. L. Cummings
Endogenous Estradiol in Elderly Individuals: Cognitive and Noncognitive Associations
Arch Neurol,
March 1, 2002;
59(3):
385 - 389.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Carlson, P. P. Zandi, B. L. Plassman, J. T. Tschanz, K. A. Welsh-Bohmer, D. C. Steffens, L. A. Bastian, K. M. Mehta, and J. C.S. Breitner
Hormone replacement therapy and reduced cognitive decline in older women: The Cache County Study
Neurology,
December 26, 2001;
57(12):
2210 - 2216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. de Moraes, M. Szklo, D. Knopman, and E. Park
Prospective Assessment of Estrogen Replacement Therapy and Cognitive Functioning: Atherosclerosis Risk in Communities Study
Am. J. Epidemiol.,
October 15, 2001;
154(8):
733 - 739.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Asthana, L. D. Baker, S. Craft, F. Z. Stanczyk, R. C. Veith, M. A. Raskind, and S. R. Plymate
High-dose estradiol improves cognition for women with AD: Results of a randomized study
Neurology,
August 28, 2001;
57(4):
605 - 612.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. H. Taber, D. D. Murphy, M. M. Blurton-Jones, and R. A. Hurley
An Update on Estrogen: Higher Cognitive Function, Receptor Mapping, Neurotrophic Effects
J Neuropsychiatry Clin Neurosci,
August 1, 2001;
13(3):
313 - 317.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. S. LeBlanc, J. Janowsky, B. K. S. Chan, and H. D. Nelson
Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis
JAMA,
March 21, 2001;
285(11):
1489 - 1499.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Wise, D. B. Dubal, M. E. Wilson, S. W. Rau, and M. Bottner
Minireview: Neuroprotective Effects of Estrogen--New Insights into Mechanisms of Action
Endocrinology,
March 1, 2001;
142(3):
969 - 973.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Seshadri, G. L. Zornberg, L. E. Derby, M. W. Myers, H. Jick, and D. A. Drachman
Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease
Arch Neurol,
March 1, 2001;
58(3):
435 - 440.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. Turner
Alzheimer's Disease in Man and Transgenic Mice : Females at Higher Risk
Am. J. Pathol.,
March 1, 2001;
158(3):
797 - 801.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Callahan, W. J. Lipinski, F. Bian, R. A. Durham, A. Pack, and L. C. Walker
Augmented Senile Plaque Load in Aged Female {beta}-Amyloid Precursor Protein-Transgenic Mice
Am. J. Pathol.,
March 1, 2001;
158(3):
1173 - 1177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Wang, S. Andersson, M. Warner, and J.-A. Gustafsson
Morphological abnormalities in the brains of estrogen receptor beta knockout mice
PNAS,
February 15, 2001;
(2001)
41617498.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P. M. Maki, A. B. Zonderman, and S. M. Resnick
Enhanced Verbal Memory in Nondemented Elderly Women Receiving Hormone-Replacement Therapy
Am J Psychiatry,
February 1, 2001;
158(2):
227 - 233.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K. Marder and M. Sano
Estrogen to treat Alzheimer's disease: Too little, too late?: So what's a woman to do?
Neurology,
June 13, 2000;
54(11):
2035 - 2037.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Wang, S. Andersson, M. Warner, and J.-A. Gustafsson
Morphological abnormalities in the brains of estrogen receptor beta knockout mice
PNAS,
February 27, 2001;
98(5):
2792 - 2796.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
